Research Article

Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis

Table 1

The baseline characteristics of the patients included.

Total patients ()Initial surgery ()Reoperation () value

Gender (n)
 Male3424100.520
 Female392415
Age (y) median (range)43 (14–90)42.5 (14–66)44 (21–90)0.709
Hospitalization time (d) mean ± SD10.6 ± 5.110.5 ± 5.410.8 ± 4.80.849
Approaches of MLND
 Transcervical7046240.973
 Transsternal321
Follow-up time (m) mean (range)42.8 (12–101)39.4 (12–101)46.9 (12–86)0.246
Histopathology (n)
 PTC6047130.658
 MTC12012
 ATC110
Prognosis n (%)1.000
 Disease-free53 (72.6)35 (72.9)18 (72.0)
 Recurrence15 (20.5)11 (22.9)4 (16.0)
 Distant metastasis4 (5.5)3 (6.3)1 (4.0)
 Death5 (6.8)3 (6.3)2 (8.0)
 Disease-specific death3 (4.1)2 (4.2)1 (4.0)

PTC: papillary thyroid carcinoma; MTC: medullary thyroid carcinoma; ATC: anaplastic thyroid carcinoma; SD: standard deviation; MLNM: mediastinal lymph node metastases.